selected publications

• article

  • Anthropometric and Genetic Factors Associated with the Exposure of Rifampicin and Isoniazid in Mexican Patients with Tuberculosis.  Therapeutic Drug Monitoring.  41:648-656. 2019-01-01
  • A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity.  Acta Pharmaceutica Sinica B.  8:188-199. 2018-01-01
  • Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3 peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.  Archives of Toxicology.  92:661-668. 2018-01-01
  • Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1.  Biochemical Pharmacology.  156:340-347. 2018-01-01
  • Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.  Leukemia and Lymphoma.  59:1968-1975. 2018-01-01
  • Analysis of transcription factors, microRNAs and cytokines involved in T lymphocyte differentiation in patients with tuberculosis after directly observed treatment short-course.  Tuberculosis.  105:1-8. 2017-01-01
  • Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.  Molecular Biology Reports.  41:7833-7843. 2014-01-01